Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

ABOUT US

Our Team Our Mission Introduction to the Avicenna Alliance Current Alliance Structure Avicenna Roadmap Avicenna Alliance Working Groups Avicenna Alliance Task Forces

VALUE STORY

What is In Silico medicine? Why do we need In Silico medicine? Why do we need a policy change?

MEMBERSHIP

Members Partners Join Avicenna

STAKEHOLDERS

Patients Policy Makers

RESOURCES

News Newsletters Publications Podcasts Glossary Press & Media Case Studies Application Brief Policy update

EVENTS

Avicenna Days Events Webinars

Follow Avicenna Alliance on:

Join Avicenna Alliance

Who should join?

Industries and research organisations who are impacted by EU policy in these areas should consider membership of the association.

Medical Devices Industry Medical Devices Industry The medical device industry has a great deal to gain from in silico medicine. Advances in modelling … Software Industry Software Industry A lack of framework for the validation of in silico models is a major barrier to those software … Pharmaceutical Industry Pharmaceutical Industry An overall declining research pipeline, rise in anti-microbial resistance coupled with a huge spike in the cost of research in recent years are a cause of concern for the pharmaceutical industry Cosmetic Industry Cosmetic Industry The recent EU ban on animal testing for cosmetic purposes has laid down the gauntlet for cosmetic … Non-Commercial Research and Academic Institutions Non-Commercial Research and Academic Institutions Research has turned into a truly competitive environment, where heterogeneous interests heavily …
Interested in Avicenna Alliance?

To find out more about how the Avicenna Alliance could benefit your industry, email Thierry Marchal:

CONTACT US!

NEWS

News Welcome DARERL to the Avicenna Alliance!

Welcome DARERL to the Avicenna Alliance!

What if medical devices could be tested on hundreds of virtual humans before being tested on a single real one?

READ MORE
News 100,000+ accesses — and counting!

100,000+ accesses — and counting!

The Avicenna Alliance is delighted to celebrate a major milestone: the In Silico book has reached 100,000 accesses!

READ MORE
News Avicenna Alliance at VPH2026: a strong community shaping the future of in silico medicine

Avicenna Alliance at VPH2026: a strong community shaping the future of in silico medicine

What a week in Milan! VPH2026 brought together around 650 experts from across the global in silico medicine community, creating an inspiring forum for exchange, collaboration and new ideas.

READ MORE
Show all activites
Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2026 Avicenna Alliance | powered by We Berry